NCT03798626 2026-01-27Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal CancersNovartisPhase 1 Completed167 enrolled
NCT03542877 2022-07-15Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal CancerUniversity of Colorado, DenverPhase 2 Completed44 enrolled 19 charts